Healthcare provider profile · identity verified

Pooja Kamboj, MD

Family Practice · EAST POINT, GA · NPI 1790308955

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	453	189
Amlodipine Besylate	Amlodipine Besylate	404	176
Albuterol Sulfate Hfa	Albuterol Sulfate	244	84
Lisinopril	Lisinopril	179	74
Rosuvastatin Calcium	Rosuvastatin Calcium	167	63
Losartan Potassium	Losartan Potassium	166	67
Metoprolol Succinate	Metoprolol Succinate	124	55
Metformin Hcl	Metformin Hcl	119	53
Hydrochlorothiazide	Hydrochlorothiazide	107	56
Gabapentin	Gabapentin	103	44
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	99	36
Omeprazole	Omeprazole	99	59
Diclofenac Sodium	Diclofenac Sodium	93	69
Trazodone Hcl	Trazodone Hcl	92	43
Furosemide	Furosemide	90	52
Levothyroxine Sodium	Levothyroxine Sodium	90	38
Ibuprofen	Ibuprofen	88	61
Carvedilol	Carvedilol	80	41
Fluticasone Propionate	Fluticasone Propionate	79	51
Triamcinolone Acetonide	Triamcinolone Acetonide	78	48
Pantoprazole Sodium	Pantoprazole Sodium	66	42
Ozempic	Semaglutide	65	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	19
Sertraline Hcl	Sertraline Hcl	54	26
Methylprednisolone	Methylprednisolone	52	43
Potassium Chloride	Potassium Chloride	50	22
Metformin Hcl Er	Metformin Hcl	48	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	41
Tamsulosin Hcl	Tamsulosin Hcl	46	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	19
Naproxen	Naproxen	44	30
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	34
Azithromycin	Azithromycin	43	35
Tramadol Hcl	Tramadol Hcl	43	18
Eliquis	Apixaban	40	15
Alendronate Sodium	Alendronate Sodium	39	18
Farxiga	Dapagliflozin Propanediol	37	14
Tizanidine Hcl	Tizanidine Hcl	34	23
Glipizide	Glipizide	33	17
Memantine Hcl	Memantine Hcl	33	suppressed
Nifedipine Er	Nifedipine	33	12
Spironolactone	Spironolactone	33	16
Allopurinol	Allopurinol	32	15
Montelukast Sodium	Montelukast Sodium	32	15
Metoprolol Tartrate	Metoprolol Tartrate	30	14
Valsartan	Valsartan	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	12
Clopidogrel	Clopidogrel Bisulfate	27	12
Hydralazine Hcl	Hydralazine Hcl	27	12
Ondansetron Odt	Ondansetron	27	15
Simvastatin	Simvastatin	26	12
Citalopram Hbr	Citalopram Hydrobromide	25	14
Torsemide	Torsemide	25	14
Hydroxyzine Hcl	Hydroxyzine Hcl	24	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	13
Duloxetine Hcl	Duloxetine Hcl	23	15
Oxybutynin Chloride Er	Oxybutynin Chloride	23	13
Chlorthalidone	Chlorthalidone	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Prednisone	Prednisone	20	16
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	18
Latanoprost	Latanoprost	17	suppressed
Mirtazapine	Mirtazapine	17	14
Famotidine	Famotidine	16	suppressed
Finasteride	Finasteride	16	suppressed
Fluconazole	Fluconazole	16	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Linzess	Linaclotide	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Nitroglycerin	Nitroglycerin	13	11
Warfarin Sodium	Warfarin Sodium	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error